Close Window

Digital Look Email A Friend

Merck shares fall as FDA pauses new patients on MS drug trial

Published by Frank Prenesti on 12th April 2023

(Sharecast News) - Shares in German pharmaceutical company Merck fell on Wednesday after the US Food and Drug Administration (FDA) placed a temporary hold on use of its multiple sclerosis evobrutinib drug on new patients.

URL: http://www.digitallook.com/dl/news/story/33429512/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.